Intravitreal Injections and Face Masks: Endophthalmitis Risk Before and During the COVID-19 Pandemic
| Autor: | Saeed Karimi, Homayoun Nikkhah, Amir Mohammadzadeh, Alireza Ramezani, Iman Ansari, Hosein Nouri, Seyed-Hossein Abtahi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Journal of Ophthalmic & Vision Research, Vol 18, Iss 3, Pp 283-288 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2008-2010 2008-322X |
| DOI: | 10.18502/jovr.v18i3.13776 |
| Popis: | Abstract Purpose: To assess the added risk of acute endophthalmitis after intravitreal injections associated with the widespread use of face masks during the COVID-19 pandemic. Methods: In this retrospective, single-center study, records of patients with acute endophthalmitis following intravitreal bevacizumab (IVB) injections during the pre-COVID era—that is, March 1 st , 2013 to October 31 st , 2019 —and the COVID-19 era—that is, March 1 st , 2020 to April 1 st , 2021 —were reviewed and compared. Results: A total of 28,085 IVB injections were performed during the pre-COVID era; nine eyes of nine patients developed acute post-IVB endophthalmitis in this era, giving an overall incidence of 0.032% (3.2 in 10,000 injections). In the COVID era, 10,717 IVB injections were performed; four eyes of four patients developed acute post-IVB endophthalmitis in this era, giving an overall incidence of 0.037% (3.7 in 10,000 injections). The incidences of post-IVB endophthalmitis during these two eras were not statistically significantly different (P = 0.779). Conclusion: Face masking protocols seem unlikely to impose any additional risk of post-IVB endophthalmitis. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|